Unilateral vs. Bilateral Lung Volume Reduction Surgery

Recruiting now · Not applicable

Conditions studied: Emphysema, Pulmonary

In brief

This study compares two surgical approaches for patients with severe Chronic Obstructive Pulmonary Disease (COPD) and severe emphysema: unilateral (operating on one lung) versus bilateral (operating on both lungs) lung volume reduction surgery (LVRS).

Key facts

Study ID

NCT07731958

Run by

Rigshospitalet, Denmark

People needed

146

Starts

2025-03-21

Expected to finish

2032-07-01

Last updated by the study team

2026-07-28

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Suitable target areas in both lungs
• Age ≥ 18 years.
• Speaks and understands Danish or English
• Informed consent obtained
• Usual inclusion criteria in LVRS:
• Moderate to severe COPD with MRC score > 2 < 75 years old 17 < BMI > 30 FEV1 > 20% and < 45% of predicted RV > 200% of predicted as a sign of relevant hyperinflation DLCO > 20% of predicted The patient should be in ideal medical treatment and have completed rehabilitation A high-resolution CT < 3 months old should follow the referral to MDT Absence of nodules suspicious of malignancy on CT scan Absence of significant comorbidity including severe cardiovascular disease LVEF normal Absence of pulmonary hypertension, TI-gradient < 40 mmHg Absence of chronic or frequent lung infections Smoking abstinence six months prior to surgery Assessed as sufficiently physically fit to undergo surgery and rehabilitation

You may not qualify if…

• Dependent on wheelchair
• Living in nursery home
• Dependent on walker device
• Psychiatric disorder (anxiety, depression, schizophrenia)
• Simultaneous lung cancer surgery
• Massive adhesions during surgery assessed by the surgeon indicating problems postoperatively
• Increased risk of post-operative bleeding assessed perioperatively by the surgeon.
• Perioperative decision on not doing operation on the other side (medical, surgical or anaesthesiologic problems that favours a fast termination of the surgery, decided by the team in OR).
• Previous cardiothoracic surgery
• Increased bleeding risk (e.g., preoperative INR >2, overdue discontinuation of anticoagulants according to guidelines by the Danish Society for Thrombosis and Haemostasis, known coagulopathy).

Where it is running

• Rigshospitalet — Copenhagen, Denmark (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.